Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Remdesivir Intermediate INT. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112645982A details a scalable synthesis of Remdesivir intermediate INT using Lewis acid catalysis and perfluorinated solvent extraction for superior purity and yield.
High-purity Remdesivir intermediate preparation via BCl3 deprotection. Reduces impurities, ensures supply chain stability for API manufacturing and cost reduction.